Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study.
N GossaiDeepa BhojwaniE S SchaferBill H ChangLauren PommertAnupam VermaJ MalvarY Y ChiJohann K HitzlerMichael J BurkeK R RabinPublished in: Leukemia (2023)